Evidence map›Paper›PMID 41739048›Full record

ReviewNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2026

The updated global burden of chronic kidney disease: one death every 20 seconds.

Alberto Ortiz, Jennifer S Lees, Roser Torra, Vianda S Stel, Anneke Kramer, Patrick B Mark

Abstract readReview
In one paragraph

Review in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alberto OrtizDivision of Nephrology and Hypertension, IIS-Fundación Jiménez Díaz-Universidad Autónoma Madrid, Spain.
Jennifer S LeesSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.ORCID 0000-0001-6331-0178
Roser TorraNephrology Department, Fundació Puigvert, Institut de Recerca Sant Pau (IR-Sant Pau), Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0001-8714-2332
Vianda S StelERA Registry, Department of Medical Informatics, Amsterdam UMC - Location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-0007-1947
Anneke KramerERA Registry, Department of Medical Informatics, Amsterdam UMC - Location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-7560-2669
Patrick B MarkSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.ORCID 0000-0003-3387-2123

Funding

European Cooperation in Science and Technology 101101220European Union PMP21/00109Instituto de Salud Carlos III PI21/00251Instituto de Salud Carlos III PI22/00050Instituto de Salud Carlos III PI22/00469Instituto de Salud Carlos III PI25/00145Sociedad Española de NefrologíaSociedad Madrileña de Nefrología CIFRA_COR-CMSociedad Madrileña de Nefrología P2022/BMD-7223Wellcome Trust 301005/Z/23/Z
6 · The paper itself

Abstract

In 2024, Global Burden of Disease (GBD) updated the forecast of global cause-specific age-standardized death rates. Chronic kidney disease (CKD) was forecast to increase by over 30% from 2022, while stroke and ischaemic heart disease would decrease by more than 40%. In western Europe, CKD would become the third cause of death by 2050. While proactive primary prevention has been key to addressing the burden of stroke and ischaemic heart disease, its role in CKD has been often neglected. In 2025, the World Health Organization and Kidney Disease: Improving Global Outcomes produced documents emphasizing maintenance of kidney health and GBD updated the global epidemiology estimates for CKD and kidney replacement therapy (KRT). The new data support the previous estimate that there are 850 million people with kidney disease globally, of whom 4.6 million are on KRT, and 1.5 million people annually (one every 20 seconds) die from CKD. In Europe, an estimated 93.1 million adults have CKD, of whom 750 000 are on KRT, and 210 000 people (one every 2.5 minutes) die from CKD. Of relevance for public health planning, diabetes and hypertension accounted for ≤30% of prevalent KRT in Europe. GBD estimates extend data currently available through the European Renal Association Registry by including additional countries where prevalence of KRT is high: Germany, for example, is home to over 77 000 people on KRT. Overall, these updated data confirm the severity of the global and European CKD burden and call for urgent action to develop novel strategies that expand beyond screening, early diagnosis and treatment of CKD to also encompass proactive primary prevention.

Indexed as

Global Burden of DiseaseGlobal HealthRenal Insufficiency, ChronicRenal Replacement TherapyHumansPrognosischronic kidney diseasedisease burdenepidemiologykidney replacement therapymortality

Identifiers

PMID41739048
PMCPMC13624808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.